My $100 was just an arbitrary number to prove the point that Anavex can't dictate the price overseas like it can in America.
As for the other points you make, we shall see. I'm willing to bet that if Anavex has solid P3 trials, someone will make Missling an offer he can't refuse knowing he might have the drug but no way of selling it, and the drugs literally have an expiration date -- when the patent ends, he better hope 371 is as good as advertised.
News 
Market Data 
Discover 
